-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Lgc3SagFe7ZFeVYXgcFx+mfItGjTy5d0NXi1f//IQd9mz2lhakWWsP1Sema/A/A1 1yB246wk2jwSb/bNESVE6g== 0001209191-09-051310.txt : 20091105 0001209191-09-051310.hdr.sgml : 20091105 20091105191857 ACCESSION NUMBER: 0001209191-09-051310 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091103 FILED AS OF DATE: 20091105 DATE AS OF CHANGE: 20091105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KIM PETER S CENTRAL INDEX KEY: 0001181180 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 091162457 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co. Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MERCK DRIVE STREET 2: P.O. BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 908 423 1688 MAIL ADDRESS: STREET 1: ONE MERCK DRIVE STREET 2: P.O. BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 4 1 c92131_4x0.xml MAIN DOCUMENT DESCRIPTION X0303 4 2009-11-03 0000310158 Merck & Co. Inc. MRK 0001181180 KIM PETER S ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889-0100 0 1 0 0 Exec. V-P and Pres., MRL Common Stock 2009-11-03 4 A 0 92641.9037 0.0000 A 0.0000 D Common Stock - 401(k) Plan 2009-11-03 4 J 0 1178.6887 0.0000 A 0.0000 I By 401(k) Phantom Stock 2009-11-03 4 A 0 37388.9370 0 A Common Stock 37388.9370 0.0000 D Restricted Stock Unit 2009-11-03 4 A 0 21600.0000 0 A 2010-03-02 2010-03-02 Common Stock 21600.0000 0.0000 D Restricted Stock Unit 2009-11-03 4 A 0 21600.0000 0 A 2011-02-28 2011-02-28 Common Stock 21600.0000 0.0000 D RSU - Leader Shares 2009-11-03 4 A 0 16000.0000 0 A 2010-03-02 2010-03-02 Common Stock 16000.0000 0.0000 D Stock Option (right to buy) 58.9105 2009-11-03 4 A 0 137149.0000 0 A 2003-03-01 2012-02-29 Common Stock 137149.0000 0.0000 D Stock Option (right to buy) 49.9626 2009-11-03 4 A 0 210998.0000 0 A 2004-02-28 2013-02-27 Common Stock 210998.0000 0.0000 D Stock Option (right to buy) 48.2400 2009-11-03 4 A 0 100000.0000 0 A 2005-02-27 2014-02-26 Common Stock 100000.0000 0.0000 D Stock Option (right to buy) 31.8400 2009-11-03 4 A 0 100000.0000 0 A 2006-02-25 2015-02-24 Common Stock 100000.0000 0.0000 D Stock Option (right to buy) 75.7638 2009-11-03 4 A 0 131874.0000 0 A 2006-03-02 2011-03-01 Common Stock 131874.0000 0.0000 D Stock Option (right to buy) 35.0900 2009-11-03 4 A 0 96000.0000 0 A 2007-03-03 2016-03-02 Common Stock 96000.0000 0.0000 D Stock Option (right to buy) 44.1900 2009-11-03 4 A 0 115200.0000 0 A 2008-03-02 2017-03-01 Common Stock 115200.0000 0.0000 D Stock Option (right to buy) 44.3000 2009-11-03 4 A 0 115200.0000 0 A 2009-02-28 2018-02-28 Common Stock 115200.0000 0.0000 D Stock Option (right to buy) 23.4500 2009-11-03 4 A 0 224000.0000 0 A 2010-04-24 2019-04-23 Common Stock 224000.0000 0.0000 D Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions"). Received as part of the Transactions in exchange for an equivalent number of shares of MSD common stock held under the MSD 401(k) plan. Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Merck Deferral Plan, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. This option vests on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. /s/ Debra A. Bollwage as Attorney-in-Fact for Peter S. Kim 2009-11-05 -----END PRIVACY-ENHANCED MESSAGE-----